32
Participants
Start Date
May 1, 2022
Primary Completion Date
December 31, 2022
Study Completion Date
December 31, 2022
BVA-100
The BVA-100 is a medical device that calculates human blood volume using the method of tracer dilution. The device utilizes a tracer of human serum albumin tagged with iodine-131 to measure injected intravascularly and a series of timed blood draws. The amount of tracer in each blood draw is used to calculate the unknown blood volume. Data inputs come from the measured characteristics of subject blood samples (hematocrit and tracer concentration) and tracer calibration standards. The package also calculates the subject expected (or ideal) blood volume from physical parameters. Hyper- or hypovolemia, associated red blood cell volumes, and tracer transudation rate are reported, with statistics showing the quality of the results.
VA Boston Healthcare System, Boston
Lead Sponsor
VA Boston Healthcare System
FED
Minneapolis Veterans Affairs Medical Center
FED
Daxor Corporation
INDUSTRY